First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS（2016）
Abstract
Drug eluting stents are considered the "gold standard" for the percutaneous treatment of coronary artery disease. Recent publications have suggested that a reasonable alternative, in well selected cases, may be the ABSORBTM bioresorbable vascular scaffold (BVS) stent. (C) 2016 Wiley Periodicals, Inc.
MoreTranslated text
Key words
stent restenosis,bioabsorbable devices/polymers,coronary artery disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined